Quick Answer
Cytek Biosciences, Inc. reported Common Stock Shares Outstanding of 128.55 million shares for the year ending 2025.
- Cytek Biosciences, Inc. showed a decrease of -0.5% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Cytek Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), Cytek Biosciences, Inc.'s Common Stock Shares Outstanding has grown by 311.5%.
- Historical annual values: Fiscal year 2025: 128.55 million shares | Fiscal year 2024: 129.21 million shares | Fiscal year 2023: 130.71 million shares | Fiscal year 2022: 135.37 million shares | Fiscal year 2021: 133.75 million shares | Fiscal year 2020: 31.24 million shares.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: